Live Oak Investment Partners »

Lumos Pharma shares owned by Live Oak Investment Partners

Quarter-by-quarter ownership of Lumos Pharma (LUMO) shares owned by Live Oak Investment Partners from 13F filings

Historical chart of Live Oak Investment Partners investment in Lumos Pharma

Tip: Access up to 7 years of quarterly data

All positions including Lumos Pharma held by Live Oak Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lumos Pharma by Live Oak Investment Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $34 11 3.18
2023-09-30 $35 11 3.27
2023-06-30 $35 11 3.27
2023-03-31 $35 11 3.27
2022-12-31 $39 11 3.55

More positions owned by Live Oak Investment Partners

Janus Short Duration (Principal) (VNLA)
Vanguard Europe Pacific ETF (Principal) (VEA)
Pgx etf (Principal) (PGX)
Ssga Active Etf Tr blkstn gsosrln (Principal) (SRLN)
First Tr Exch Traded Fund Ii lng/sht equity (Principal) (FTLS)
Invesco Exchange Traded Fd T rusel mdcp eql (Principal) (XMHQ)
iShares S&P SmallCap 600 Index (Principal) (IJR)
IQ Hedge Multi-Strategy Tracker (Principal) (QAI)
Vanguard Information Technology ETF (Principal) (VGT)
Apple (Principal) (AAPL)
Merck & Co (Principal) (MRK)
Vanguard Health Care ETF (Principal) (VHT)
Netflix (Principal) (NFLX)
AutoZone (Principal) (AZO)
Ishares Inc msci emrg chn (Principal) (EMXC)

View all positions for Live Oak Investment Partners

Top funds holding Lumos Pharma

Wells Fargo & Company
Goldman Sachs Group
Vanguard Group
Acuitas Investments
Leucadia National Corporation
Lion Point Capital
Blackstone Group
Greenwich Wealth Management
Geode Capital Management
BlackRock
Two Sigma Investments
Millennium Management
Two Sigma Advisers
Dimensional Fund Advisors
Bridgeway Capital Management

View all funds holding Lumos Pharma